Location: Blacksburg, Va.

Founder: Josep Bassaganya-Riera

Founding Date: 2017

Financing: $10m from Perceptive Advisors

Disease Area: Crohn's and ulcerative coloitis

R&D Focus: Oral, locally acting drugs for auto-immune diseases

Patents: Composition of matter and method of use patents through 2035

Management Team: Josep Bassaganya-Riera (CEO); Raquel Hontecillas (CSO); Andrew Leber (Scientific Director); Chris Garabedian (Senior Business Advisor)

Board of Directors: Josep Bassaganya-Riera; Chris Garabedian Clinical Advisory Board, IBD: Francisco Sylvester (CCFA); Fabio Cominelli UH Case Medical Center; William Sandborn (UCSD); Jean-Frederic Columbel (IBD Center, Mount Sinai); Maria Abreu (University of Miami)

Employees: 18

Landos Leverages Advanced Computing For Autoimmune Disease Drug Development

More from Start-Ups & SMEs

More from Business